Education
About Us
Working with TipRanks
Follow Us
Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN
Total Valuation
Tevogen Bio Holdings has a market cap or net worth of $183.89M. The enterprise value is $70.13M.
Market Cap$183.89M
Enterprise Value$70.13M
Share Statistics
Tevogen Bio Holdings has 183.89M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding183.89M
Owened by Insiders82.84%
Owened by Instutions0.03%
Financial Efficiency
Tevogen Bio Holdings’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -0.06%.
Return on Equity (ROE)9.68%
Return on Assets (ROA)-0.40%
Return on Invested Capital (ROIC)-0.06%
Return on Capital Employed (ROCE)-0.06%
Revenue Per Employee$0
Profits Per Employee-$283,986.167
Employee Count18
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Tevogen Bio Holdings is -27.32K. Tevogen Bio Holdings’s PEG ratio is 270.28.
PE Ratio-27.32K
PS Ratio0.00
PB Ratio-2.64K
Price to Fair Value-2.64K
Price to FCF-1.34K
Price to Operating Cash Flow-1.34K
PEG Ratio270.28
Income Statement
In the last 12 months, Tevogen Bio Holdings had revenue of $0.00 and earned -$5.11M in profits. Earnings per share was -$0.05.
Revenue$0.00
Gross Profit-$198.29K
Operating Income-$44.85M
Pretax Income-$5.11M
Net Income-$5.11M
EBITDA-3.31M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -$9.64M and capital expenditures $0.00, giving a free cash flow of -$9.64M billion.
Operating Cash Flow-$9.64M
Free Cash Flow-$9.64M
Free Cash Flow per Share-$0.05
Dividends & Yields
Tevogen Bio Holdings pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-0.07%
Earnings Yield>-0.01%
Stock Price Statistics
Beta0.02
52-Week Price Change-54.04%
50-Day Moving Average1.26
200-Day Moving Average1.06
Relative Strength Index (RSI)40.89
Average Volume (3m)552.21K
Important Dates
Tevogen Bio Holdings upcoming earnings date is Apr 30, 2025, Before Open.
Last Earnings DateNov 19, 2024
Next Earnings DateApr 30, 2025
Ex-Dividend Date―
Financial Position
Tevogen Bio Holdings as a current ratio of 0.12, with Debt / Equity ratio of -2.35
Current Ratio0.12
Quick Ratio0.12
Debt to Market Cap<0.01
Net Debt to EBITDA8.60
Interest Coverage Ratio-0.03
Taxes
In the past 12 months, Tevogen Bio Holdings has paid $48.58M in taxes.
Income Tax$48.58M
Effective Tax Rate0.00%
Enterprise Valuation
Tevogen Bio Holdings EV to EBITDA ratio is 9.76K, with an EV/FCF ratio of -1.34K.
EV to Sales0.00
EV to EBITDA9.76K
EV to Free Cash Flow-1.34K
EV to Operating Cash Flow-1.34K
Balance Sheet
Tevogen Bio Holdings has $2.33M in cash and marketable securities with $2.96M in debt, giving a net cash position of $633.86K billion.
Cash & Marketable Securities$2.33M
Total Debt$2.96M
Net Cash$633.86K
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Tevogen Bio Holdings is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside825.93%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast
EPS Growth Forecast-20.39%